BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹16,927 Cr | ₹15,262 Cr | ₹14,756 Cr | ₹11,174 Cr | ₹8,184 Cr |
What is the latest Revenue of BIOCON ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹16,927 Cr |
| Mar2025 | ₹15,262 Cr |
| Mar2024 | ₹14,756 Cr |
| Mar2023 | ₹11,174 Cr |
| Mar2022 | ₹8,184 Cr |
How is Revenue of BIOCON Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹16,927 Cr | 10.91 | |
| Mar2025 | ₹15,262 Cr | 3.43 | |
| Mar2024 | ₹14,756 Cr | 32.05 | |
| Mar2023 | ₹11,174 Cr | 36.54 | |
| Mar2022 | ₹8,184 Cr | - | |
Compare Revenue of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹69,262.3 Cr | -1.3% | 0.1% | 9.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1.3% |
0.1% |
9.2% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses